MAP is a leading congress in precision medicine in oncology, established by key opinion leaders in the field.
Access the congress platform
The name of the Congress was recently changed into Molecular Analysis for Precision Oncology to better reflect its aims of focusing on science, translational research, education and collaboration.
CRUK, ESMO and Unicancer are excited to announce that, due to the Coronavirus pandemic, this year’s edition will be held virtually on October 9-10.
MAP 2020 will offer the same top-tier scientific research and education and industry engagement that congress attendees are accustomed to, in an all-new digital environment.
By attending the MAP 2020 Virtual Congress, participants will learn how to integrate insights from tumour sample analysis into daily practice, how to seek and identify actionable mutations in patient DNA and how to provide the best possible personalised treatment.
Founded by Jean-Charles Soria, Fabrice André and Charles Swanton, the MAP Congress has established itself as a point of reference for all specialists wishing to create a bright future for precision medicine in oncology, by delivering a highly specific, minimally toxic and dramatically effective treatment for each patient.
The MAP Congress is the result of a close partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.
We hope to see you online at our meeting in October!